Beta Drugs shareholding pattern

BETA

HealthcareSmall

1926.5

11.50 (0.60%)
Last updated on 18 Aug, 2025 | 15:30 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Beta Drugs Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2025-26
  • 2024-25
Total Promoters
Segment
Percent

Total Promoters

66.73%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.15%

Domestic Institutional Investors

0.15%

Retail

31.96%

Others

0.01%

Total Promoters
MAR '24
66.73%
JUN '24
66.73%
SEP '24
66.73%
DEC '24
66.73%

Beta Drugs FAQs

As of 08-2025, the promoter shareholding in Beta Drugs stands at 66.73% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Beta Drugs is 0.9% and 0.24% respectively.

The retail shareholding of the Beta Drugs is 32.12%.

Changes in shareholding patterns of Beta Drugs can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Beta Drugs are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.